abstract |
Mesenchymal stem cells (MSCs) for use in treating a tumor, wherein said treatment comprises the combined administration of said MSCs with an antitumor immunotherapy, wherein said immunotherapy comprises the administration of T lymphocytes and / or natural killer (NK) lymphocytes , and where said MSCs are not genetically modified. |